{"id":"W2998909083","doi":"10.1016/s0923-7534(20)33028-3","title":"Phase I Study to Compare Safety and Pharmacokinetics of Afatinib, An Oral Irreversible Erbb Family Blocker, in Non-Cancer Subjects with Hepatic Impairment to Matched Healthy Subjects","year":2012,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Afatinib; Pharmacokinetics; Oncology; Internal medicine; Cancer; ErbB; Pharmacology; Erlotinib; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008890752,0.001236321,0.002255479,0.0003588565,0.0005367005,0.0007111446,0.0006349077,0.00107957,0.003791222],"category_scores_gemma":[0.001314543,0.0005396838,0.001084115,0.0003788375,0.0008907646,0.0008610307,0.0002652424,0.002074664,0.0007375754],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007416504,"about_ca_system_score_gemma":0.001025777,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00118394,"about_ca_topic_score_gemma":0.001295733,"domain_scores_codex":[0.9995887,0.0001698526,0.00001865043,0.0001106389,0.00003484868,0.00007736695],"domain_scores_gemma":[0.9990088,0.0002184469,0.0001978662,0.0001083425,0.00006507372,0.0004015569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9266633,0.02062858,0.00894568,0.0001756503,0.001002772,0.00017308,0.0001082022,0.0006857665,0.02012367,0.000116428,0.0009195294,0.02045725],"study_design_scores_gemma":[0.4606205,0.4978088,0.03292233,0.00001323623,0.001055387,0.000442185,0.00008952201,0.0009316135,0.004234141,0.0002372544,0.00160173,0.00004342925],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964065,0.0008189491,0.0004429701,0.0001447269,0.00006626245,0.0006318829,0.0006541866,0.00005499305,0.0007794636],"genre_scores_gemma":[0.9952071,0.0004638856,0.000539629,0.0003926763,0.000129306,0.0006928896,0.00110806,0.00002078366,0.001445622],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003791222,"threshold_uncertainty_score":0.01268286,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09833943599749505,"score_gpt":0.4635923705557501,"score_spread":0.3652529345582551,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}